Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.

Podobne knjige/članki

• Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
  od: Lichtenstein, G, et al.
  Izdano: (2015)
• Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
  od: Sandborn, W, et al.
  Izdano: (2015)
• Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
  od: Sandborn, W, et al.
  Izdano: (2012)
• Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies
  od: Sandborn, W, et al.
  Izdano: (2011)
• Induction of remission with oral budesonide MMX (R) (9 mg) tablets in oatients with mild to moderate, active Ulcerative Colitis: A multicenter, open-label efficacy and safety study
  od: Travis, S, et al.
  Izdano: (2011)